Jump to: navigation, search

transient receptor potential cation channel, subfamily V, member 1 [Homo sapiens]
Symbol(s) TRPV1; DKFZp434K0220; VR1
External IDs OMIM: 602076 MGI1341787 Homologene12920
RNA expression pattern


More reference expression data

Human Mouse
Entrez 7442 193034
Ensembl ENSG00000196689 ENSMUSG00000005952
Uniprot Q8NER1 Q3V318
Refseq NM_018727 (mRNA)
NP_061197 (protein)
NM_001001445 (mRNA)
NP_001001445 (protein)
Location Chr 17: 3.42 - 3.45 Mb Chr 11: 73.05 - 73.08 Mb
Pubmed search [1] [2]

The Transient receptor potential vanilloid 1 or TRPV1 can refer to the TRP cation channel receptor or the gene which encodes it in Homo sapiens.

TRPV1 is a nonselective ligand-gated cation channel that may be activated by a wide variety of exogenous and endogenous stimuli, including heat greater than 43°C, low pH, anandamide, N-arachidonoyl-dopamine, and capsaicin. TRPV1 receptors are found in the central nervous system and the peripheral nervous system and are involved in the transmission and modulation of pain, as well as the integration of diverse painful stimuli.[1][2]

Clinical significance

Peripheral nervous system

TRPV1 antagonists have shown efficacy in reducing nociception from inflammatory and neuropathic pain models in rats.[3] This provides evidence that TRPV1 is the capsaicin's sole receptor.[4]

In humans, drugs acting at TRPV1 receptors could potentially be used to treat neuropathic pain associated with multiple sclerosis, chemotherapy, or amputation, as well as pain associated with the inflammatory response of damaged tissue, such as in osteoarthritis.[5]

Central nervous system

TRPV1 is also expressed at high levels in the central nervous system and has been proposed as a target for treatment of not only pain but also for other conditions such as anxiety.[6] Furthermore TRPV1 appears to mediate long term depression (LTD) in the hippocampus.[7] LTD has been linked to a decrease in the ability to make new memories, unlike its opposite long term potentiation (LTP), which aids in memory formation. In rat brain slices, activation of TRV1 with heat or capsaicin induced LTD while capsazepine blocked capsaicin's ability to induce LTD.[7] Hence there may be therapeutic potential in antagonizing TRPV1 in the central nervous system, perhaps as a treatment for epilepsy (TRPV1 is already a target in the peripheral nervous system for pain relief).

See also


  1. Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, Marsh K, Bianchi B, McDonald H, Niforatos W, Neelands TR, Moreland RB, Decker MW, Lee CH, Sullivan JP, Faltynek CR (2006). "TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists". J. Neurosci. 26 (37): 9385–93. PMID 16971522. doi:10.1523/JNEUROSCI.1246-06.2006. 
  2. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V (2002). "An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors". Proc. Natl. Acad. Sci. U.S.A. 99 (12): 8400–5. PMID 12060783. doi:10.1073/pnas.122196999. 
  3. Jhaveri MD, Elmes SJ, Kendall DA, Chapman V (2005). "Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats". Eur. J. Neurosci. 22 (2): 361–70. PMID 16045489. doi:10.1111/j.1460-9568.2005.04227.x. 
  4. Story GM, Crus-Orengo L (2008). "Feel the Burn". American Scientist. 95 (4): 326–333. ISSN 0003-0996. 
  5. Gunthorpe MJ, Szallasi A (2008). "Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms". Curr. Pharm. Des. 14 (1): 32–41. PMID 18220816. 
  6. Starowicz K, Cristino L, Di Marzo V (2008). "TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications". Curr. Pharm. Des. 14 (1): 42–54. PMID 18220817. 
  7. 7.0 7.1 Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA (2008). "TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons". Neuron. 57 (5): 746–59. PMID 18341994. doi:10.1016/j.neuron.2007.12.027. 

Further reading

  • Heiner I, Eisfeld J, Lückhoff A (2004). "Role and regulation of TRP channels in neutrophil granulocytes.". Cell Calcium. 33 (5-6): 533–40. PMID 12765698. 
  • Geppetti P, Trevisani M (2004). "Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.". Br. J. Pharmacol. 141 (8): 1313–20. PMID 15051629. doi:10.1038/sj.bjp.0705768. 
  • Clapham DE, Julius D, Montell C, Schultz G (2006). "International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.". Pharmacol. Rev. 57 (4): 427–50. PMID 16382100. doi:10.1124/pr.57.4.6. 
  • Szallasi A, Cruz F, Geppetti P (2007). "TRPV1: a therapeutic target for novel analgesic drugs?". Trends in molecular medicine. 12 (11): 545–54. PMID 16996800. doi:10.1016/j.molmed.2006.09.001. 
  • Pingle SC, Matta JA, Ahern GP (2007). "Capsaicin receptor: TRPV1 a promiscuous TRP channel.". Handb Exp Pharmacol (179): 155–71. PMID 17217056. doi:10.1007/978-3-540-34891-7_9. 
  • Liddle RA (2007). "The role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in pancreatitis.". Biochim. Biophys. Acta. 1772 (8): 869–78. PMID 17428642. doi:10.1016/j.bbadis.2007.02.012. 

External links